Mallinckrodt PLC, one of the drug manufacturers being sued in opioid-related litigation, agreed to pay “$24 million in cash and provide $6 million worth of generic products, including those for addiction treatment” to two counties in Ohio to settle the claims against it. Recently, Mallinckrodt hired a consulting firm to assist with restructuring. The company still faces over one hundred other lawsuits.